No Data
No Data
The Market Lifts Guangzhou Wondfo Biotech Co.,Ltd (SZSE:300482) Shares 40% But It Can Do More
Guangzhou Wondfo Biotech (300482.SZ): The new coronavirus home testing (OTC) product has received pre-market notification from the USA FDA.
GeLongHui October 8th | guangzhou wondfo biotech (300482.SZ) announced that the company recently received a notification from the USA Food & Drug Administration (USA Food and Drug Administration, hereinafter referred to as "FDA"), notifying that guangzhou wondfo biotech's new coronavirus family test kit (OTC version) Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) has received a US FDA 510(K) pre-market notification. The company's new coronavirus family test (OTC) kit.
Guangzhou Wondfo BiotechLtd (SZSE:300482) Will Be Hoping To Turn Its Returns On Capital Around
Guangzhou Wondfo Biotech (300482.SZ) 27.451 million restricted shares will be listed for trading on October 8th.
Guangzhou Wondfo Biotech (300482.SZ) announced that the company will lift the restricted shares this time, with a quantity of 27.451 million shares, accounting for...
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Profits May Not Reveal Underlying Issues
Wondfo Biotech Gets Green Light to Sell Fentanyl Tests in US; Shares Down 5%
No Data
No Data